- Home
- FGL vs GDTC Comparison
FGL vs GDTC Comparison
Compare FGL & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- GDTC
- Stock Information
- Founded
- FGL 2021
- GDTC 2018
- Country
- FGL Malaysia
- GDTC Singapore
- Employees
- FGL N/A
- GDTC N/A
- Industry
- FGL
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- FGL
- GDTC Health Care
- Exchange
- FGL NYSE
- GDTC Nasdaq
- Market Cap
- FGL 25.4M
- GDTC 28.0M
- IPO Year
- FGL 2024
- GDTC 2023
- Fundamental
- Price
- FGL $1.28
- GDTC $2.35
- Analyst Decision
- FGL
- GDTC Buy
- Analyst Count
- FGL 0
- GDTC 1
- Target Price
- FGL N/A
- GDTC $5.00
- AVG Volume (30 Days)
- FGL 34.2K
- GDTC 9.6K
- Earning Date
- FGL 06-21-2025
- GDTC 01-01-0001
- Dividend Yield
- FGL N/A
- GDTC N/A
- EPS Growth
- FGL N/A
- GDTC N/A
- EPS
- FGL N/A
- GDTC N/A
- Revenue
- FGL $20,205,441.00
- GDTC $368,838.00
- Revenue This Year
- FGL N/A
- GDTC $5.37
- Revenue Next Year
- FGL N/A
- GDTC N/A
- P/E Ratio
- FGL N/A
- GDTC N/A
- Revenue Growth
- FGL N/A
- GDTC N/A
- 52 Week Low
- FGL $1.16
- GDTC $1.20
- 52 Week High
- FGL $5.26
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- GDTC 49.94
- Support Level
- FGL N/A
- GDTC $2.26
- Resistance Level
- FGL N/A
- GDTC $2.60
- Average True Range (ATR)
- FGL 0.00
- GDTC 0.13
- MACD
- FGL 0.00
- GDTC 0.00
- Stochastic Oscillator
- FGL 0.00
- GDTC 40.38
About FGL FOUNDER GROUP LTD
Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.